CHELSIE MAY: Open Payments
NPI 1619721420 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 45 payments from 22 companies in 2025. Trend: 2023 $19 · 2024 $886 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $203 |
| E.R. Squibb & Sons, L.L.C. | 6 | $110 |
| Incyte Corporation | 3 | $68 |
| Stemline Therapeutics Inc. | 2 | $48 |
| Geron Corporation | 2 | $46 |
| PFIZER INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Astellas Pharma US Inc | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $33 |
Products named: RYBREVANT, Orserdu, OPDIVO, TALVEY, RYTELO, MONJUVI, OJJAARA, ERLEADA.
Industry payments across TX — which companies pay providers there.
